Human Milk Oligosaccharides at the Interface of Maternal–Infant Health | Zendy

Lars Bode | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Human Milk Oligosaccharides at the Interface of Maternal–Infant Health

Author(s) -

Lars Bode

Publication year - 2018

Publication title -

breastfeeding medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.661

H-Index - 45

eISSN - 1556-8342

pISSN - 1556-8253

DOI - 10.1089/bfm.2018.29073.ljb

Subject(s) - breastfeeding , medicine , infant formula , breast feeding , infant nutrition , infant feeding , interface (matter) , breast milk , food science , environmental health , pediatrics , population , biochemistry , research methodology , biology , pulmonary surfactant , gibbs isotherm

Human milk oligosaccharides (HMOs) are a family of structurally diverse, complex sugars abundant in breast milk.1 HMO concentrations in human milk often exceed the concentration of all human milk proteins combined (Table 1). HMO profiles can vary based on genetics and geographic location, and can change over the course of lactation.1,2 HMOs are resistant to low pH and intestinal enzymes and are found in the urine and feces of breastfed infants. The oligosaccharides currently added to infant formula are structurally distinct from HMOs; however, some brands are beginning to include certain HMOs in newer formulas.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research